Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01514383 · ClinicalTrials.gov registry record · Phase 4

Octylseal Surgical Adhesive in General Surgery

A Phase 4 study of Wounds, sponsored by Medline Industries.

Completed
Registry status
Phase 4
Development phase
34
Enrollment target
2
Study locations

NCT01514383: Completed Phase 4 study of Wounds, sponsored by Medline Industries.

NCT01514383 is a Phase 4 study of Wounds that has completed, run by Medline Industries. The registered enrollment target is 34 participants, below the 97-participant average among 6 other Wounds trials with a reported enrollment target (65% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01514383, a Phase 4 study of Wounds, has completed, sponsored by Medline Industries.

COMPLETED
Registry status
Phase 4
Development phase
34 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to evaluate how surgical adhesive is used.

Primary Outcome

Primary incision wound length treatment in adult and pediatric general surgery

Conditions Studied

Interventions

  • DEVICE Cyanoacrylate (Octylseal )

Study Locations (2)

New Jersey

  • Jersey City Medical Center - Jersey City

New York

  • Wyckoff Hospital - New York

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2012-01
Est. Completion 2012-10
Phase Phase 4
Medline Industries

24 total trials

What the finished NCT01514383 record still lists

NCT01514383 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 97-participant average among 6 other Wounds trials with a reported enrollment target (65% lower).

The record links to 1 condition, with Wounds appearing as the primary indexed condition, and to 1 intervention - of which Cyanoacrylate (Octylseal ) is the first listed.

NCT01514383 reports a single indexed study location in New Jersey, New York.

Frequently Asked Questions

What is clinical trial NCT01514383 about?

NCT01514383 is a clinical study titled "Octylseal Surgical Adhesive in General Surgery". The purpose of this study is to evaluate how surgical adhesive is used.

What is the current status of trial NCT01514383?

This trial is currently completed. It is a Phase 4 study. The enrollment target is 34 participants. The study started on 2012-01. Estimated completion is 2012-10.

What conditions does trial NCT01514383 study?

This clinical trial studies the following conditions: Wounds.

What interventions are being tested in trial NCT01514383?

The interventions under investigation include: Cyanoacrylate (Octylseal ) (DEVICE).

Who is sponsoring clinical trial NCT01514383?

This trial is sponsored by Medline Industries, which has 24 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01514383 being conducted?

This trial has 2 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wounds

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01514383, the US trial registry maintained by the National Library of Medicine. NCT01514383 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.